GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,517 Cr | ₹1,559 Cr | ₹871 Cr | ₹1,075 Cr | ₹671 Cr |
What is the latest Sundry Debtors ratio of GLAND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,517 Cr |
| Mar2024 | ₹1,559 Cr |
| Mar2023 | ₹871 Cr |
| Mar2022 | ₹1,075 Cr |
| Mar2021 | ₹671 Cr |
How is Sundry Debtors of GLAND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,517 Cr | -2.70 | |
| Mar2024 | ₹1,559 Cr | 78.87 | |
| Mar2023 | ₹871 Cr | -18.93 | |
| Mar2022 | ₹1,075 Cr | 60.19 | |
| Mar2021 | ₹671 Cr | - | |
Compare Sundry Debtors of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹27,247.2 Cr | -1.1% | -7.8% | -6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.1% |
-7.8% |
-6.6% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses